890
Views
32
CrossRef citations to date
0
Altmetric
Review

Proton pump inhibitors (PPIs) may cause gastric cancer – clinical consequences

, &
Pages 639-642 | Received 27 Jan 2018, Accepted 06 Mar 2018, Published online: 31 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Taraneh Mousavi, Shekoufeh Nikfar & Mohammad Abdollahi. (2022) The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opinion on Pharmacotherapy 23:1, pages 63-89.
Read now
Shih-Wei Lai. (2019) Association between proton pump inhibitors therapy and the risk of gastric cancer. Scandinavian Journal of Gastroenterology 54:3, pages 390-390.
Read now

Articles from other publishers (30)

Laura Gil-Vicente, Germán Martín, Carme Soler, Anna Vila, María Rocío Saiz & Paula F. Navarro. (2024) Prospective Randomized Controlled Clinical Trial of the Long-Term Effects of Omeprazole on Healthy Dogs. Animals 14:8, pages 1168.
Crossref
Ibrahim O. Sawaid & Abraham O. Samson. (2024) Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence. Journal of Clinical Medicine 13:7, pages 1970.
Crossref
Ahmed A. Morsi, Lamiaa M. Shawky, Tamer M. Shawky, Mohamed H. Bahr, Mahmoud Tawfiq Abu Alnasr & Eman El Bana. (2024) Targeting NF‐κB/COX‐2 signaling by soyasaponin I alleviates diclofenac‐induced gastric ulceration in male albino rats. Cell Biochemistry and Function 42:1.
Crossref
Tien Tran, Seung-Kwon Myung & Thao Thi Trinh. (2023) Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies. Oncology Letters 27:1.
Crossref
Risha Kumari & Shweta Agarwal. (2023) Role of Proton Pump Inhibitors in the Management of Peptic Ulcer. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 16:6, pages 7070-7080.
Crossref
Sofie Lieberoth, Frederik Friis-Hansen & Lennart Friis-Hansen. (2023) Paediatric reference ranges for plasma chromogranin A. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.
Crossref
Rachel Gingold-Belfer, Nidal Issa, Doron Boltin, Yichayaou Beloosesky, Nira Koren-Morag, Joseph Meyerovitch, Eran Sharon, Noam Peleg & Hemda Schmilovitz-Weiss. (2023) Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use. European Journal of Gastroenterology & Hepatology 35:9, pages 968-973.
Crossref
Anuj Shah & Min P. Kim. (2023) Gastroesophageal Reflux Disease in 2023. Thoracic Surgery Clinics 33:2, pages 125-134.
Crossref
Natalia M. Khomeriki & Sergey G. Khomeriki. (2023) Is an optimization of the use of proton pump inhibitors feasible in the real world medical practice?. Almanac of Clinical Medicine 50:6, pages 357-366.
Crossref
Laboni Das & Kamalika Sen. (2022) Amino Acid and Block Copolymer-Based ABS: An Efficient Extraction Tool for PPIs and Consequent Recovery of the Polymer. Journal of Chemical & Engineering Data 68:1, pages 173-182.
Crossref
Tai Zhang, Beihua Zhang, Jinkang Xu, Shunping Ren, Shaogang Huang, Zhaohong Shi, Shaoju Guo, Liqun Bian, Ping Wang, Fengyun Wang, Yidong Cai & Xudong Tang. (2022) Chinese herbal compound prescriptions combined with Chinese medicine powder based on traditional Chinese medicine syndrome differentiation for treatment of chronic atrophic gastritis with erosion: a multi-center, randomized, positive-controlled clinical trial. Chinese Medicine 17:1.
Crossref
Tahmina Nasrin Poly, Ming-Chin Lin, Shabbir Syed-Abdul, Chih-Wei Huang, Hsuan-Chia Yang & Yu-Chuan (Jack) Li. (2022) Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal. Cancers 14:13, pages 3052.
Crossref
Bando TY, di Pace LS, Lapa M & Chehter EZ. (2022) Proton pump inhibitors: Are they safe?. Gastroenterology & Hepatology: Open Access 13:2, pages 34-47.
Crossref
Gwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, Hong Jun Park, Sung Woo Jung, Ok-Jae Lee, Hyungkil Kim, Hoon Jai Chun, Soo Teik Lee, Ji Won Kim, Han Ho Jeon, Il-Kwun Chung, Hyun-Soo Kim, Dong Ho Lee, Kyoung-Oh Kim, Yun Jeong Lim, Seun-Ja Park, Soo-Jeong Cho, Byung-Wook Kim, Kwang Hyun Ko, Seong Woo Jeon, Jae Gyu Kim, In-Kyung Sung, Tae Nyeun Kim, Jae Kyu Sung & Jong-Jae Park. (2021) Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study. Gut and Liver 15:6, pages 841-850.
Crossref
Seungkyung Kang & Soo-Jeong Cho. (2021) Proton Pump Inhibitors and Gastric Cancer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 21:3, pages 173-179.
Crossref
Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Takahiro Uotani, Mihoko Yamade, Shinya Tani, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima & Takahisa Furuta. (2021) Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia. European Journal of Clinical Pharmacology 77:7, pages 971-978.
Crossref
Helge Waldum. (2021) Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers 13:13, pages 3159.
Crossref
Helge Waldum & Reidar Fossmark. (2021) Gastritis, Gastric Polyps and Gastric Cancer. International Journal of Molecular Sciences 22:12, pages 6548.
Crossref
Joshua Bilello & Ikenna Okereke. (2021) Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome. Biomedicines 9:6, pages 617.
Crossref
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes-Koninckx, Mike Thomson, Michael Wilschanski & Nikhil Thapar. (2021) Drugs in Focus: Proton Pump Inhibitors. Journal of Pediatric Gastroenterology & Nutrition 72:5, pages 645-653.
Crossref
Fernanda Cristina Stenger Moura, Valdir Cechinel-Filho, Francesco Antonio Greco, Larissa Venzon, Mariane Caroline Meurer, Tauani Caroline dos Santos França, Bruna Longo, Lincon Bordignon Somensi, Luisa Nathalia Bolda Mariano, Alexandre Bella Cruz, Antonio Macchiarulo, Aurélie Schoubben, Maurizio Ricci, Tania Mari Belle Bresolin & Luisa Mota da Silva. (2021) Taxifolin and gastro-adhesive microparticles containing taxifolin promotes gastric healing in vivo, inhibits Helicobacter pylori in vitro and proton pump reversibly in silico. Chemico-Biological Interactions 339, pages 109445.
Crossref
Takamitsu Sasaki, Shiori Mori, Shingo Kishi, Rina Fujiwara-Tani, Hitoshi Ohmori, Yukiko Nishiguchi, Yudai Hojo, Isao Kawahara, Chie Nakashima, Kiyomu Fujii, Yi Luo & Hiroki Kuniyasu. (2020) Effect of Proton Pump Inhibitors on Colorectal Cancer. International Journal of Molecular Sciences 21:11, pages 3877.
Crossref
Jinkun Guo & Zhongyin Zhou. (2020) Proton pump inhibitors and stomach neoplasm. Oncology and Translational Medicine 6:1, pages 26-29.
Crossref
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Nele Brusselaers, Jesper Lagergren & Lars Engstrand. (2019) Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiology 62, pages 101585.
Crossref
Cüneyt Türkeş. (2019) A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors† . Journal of Pharmacy and Pharmacology 71:10, pages 1553-1564.
Crossref
Moon Kyung Joo, Jong-Jae Park & Hoon Jai Chun. (2019) Proton pump inhibitor: The dual role in gastric cancer. World Journal of Gastroenterology 25:17, pages 2058-2070.
Crossref
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade & Romain Coriat. (2019) Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?. La Presse Médicale 48:5, pages 503-510.
Crossref
Ka Shing Cheung & Wai K. Leung. (2019) Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence. Therapeutic Advances in Gastroenterology 12, pages 175628481983451.
Crossref
Stuart Jon Spechler. (2019) Proton Pump Inhibitors. Medical Clinics of North America 103:1, pages 1-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.